Natus Medical Incorporated
NTUS · NASDAQ
3/31/2022 | 12/31/2021 | 9/30/2021 | 6/30/2021 | |
|---|---|---|---|---|
| Market Cap | $900,773 | $802,050 | $843,641 | $873,889 |
| - Cash | $84,285 | $75,595 | $68,779 | $62,494 |
| + Debt | $10,237 | $11,531 | $12,537 | $13,914 |
| Enterprise Value | $826,725 | $737,986 | $787,399 | $825,309 |
| Revenue | $119,793 | $128,656 | $113,877 | $115,978 |
| % Growth | -6.9% | 13% | -1.8% | – |
| Gross Profit | $65,412 | $73,043 | $67,748 | $66,401 |
| % Margin | 54.6% | 56.8% | 59.5% | 57.3% |
| EBITDA | $10,314 | $10,602 | $14,716 | $13,112 |
| % Margin | 8.6% | 8.2% | 12.9% | 11.3% |
| Net Income | $1,903 | $1,745 | $5,573 | $3,464 |
| % Margin | 1.6% | 1.4% | 4.9% | 3% |
| EPS Diluted | 0.056 | 0.051 | 0.16 | 0.1 |
| % Growth | 8.6% | -68.1% | 60% | – |
| Operating Cash Flow | $8,897 | $12,782 | $7,116 | $19,393 |
| Capital Expenditures | -$1,062 | -$671 | -$982 | -$1,236 |
| Free Cash Flow | $7,835 | $12,111 | $6,134 | $18,157 |